4//SEC Filing
Xia Yu 4
Accession 0001599298-24-000008
CIK 0001599298other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:19 PM ET
Size
8.0 KB
Accession
0001599298-24-000008
Insider Transaction Report
Form 4
Xia Yu
Director
Transactions
- Award
Stock Option (right to buy)
2024-01-02+200,000→ 235,000 totalExercise: $2.64Exp: 2034-01-02→ Common Stock (200,000 underlying) - Award
Stock Option (right to buy)
2024-01-02+35,000→ 35,000 totalExercise: $2.64Exp: 2034-01-02→ Common Stock (35,000 underlying)
Footnotes (3)
- [F1]The option was granted on January 2, 2024. The shares underlying the option shall vest in four equal quarterly installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the director remaining as a non-salaried director on each such vesting date.
- [F2]Not applicable.
- [F3]The option was granted on January 2, 2024. The shares underlying the option are scheduled to vest in four equal annual installments, with the first such installment occurring on January 2, 2025.
Documents
Issuer
Summit Therapeutics Inc.
CIK 0001599298
Entity typeother
Related Parties
1- filerCIK 0001963544
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 4:19 PM ET
- Size
- 8.0 KB